General MM,   Patients eligible for transplant,  Patients non-eligible for transplant,   & 1 more

ASH 2019 | Practice-changing abstracts in multiple myeloma

Did you miss ASH 2019? The Multiple Myeloma Hub attended the 61st ASH Annual Meeting & Exposition, December 7-10 2019, Orlando, US, and has developed a downloadable resource on the practice-changing abstracts in multiple myeloma (MM). 

In this resource, you will find comments from the MM Hub Steering Committee members on treating newly diagnosed patients with MM non-eligible for transplant, treating newly diagnosed patients with MM eligible for transplant, treating newly diagnosed patients with relapsed or refractory MM, autologous stem cell transplantation, treating patients with smoldering myeloma, CAR T-cell therapy and BiTEs, prognostic factors, and novel targets.

ASH 2019 | Practice-changing abstracts in multiple myeloma

If you would like to view the practice-changing abstracts from ASH 2019 and the expert opinions from our Steering Committee, please download the resource below

Download Here
Was this article informative? Thank you for your feedback!
100% of people found this article informative